Back to News

Orion Pharma joins IQ Consortium

Orion Pharma joins IQ Consortium

May 25, 2023

 

The IQ Consortium is excited to announce its newest member, Orion Pharmaceutics. Orion Pharma is a globally operating Finnish company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. 

Orion Pharma will be represented on the IQ Board of Directors by Dr. Riikka Oksala and Mikko Koskinen.